Department of Biomedical Informatics, Arizona State University, Mayo Clinic - Samuel C, Johnson Research Bldg, 13212 East Shea Boulevard, Scottsdale, AZ 85259, USA.
BMC Bioinformatics. 2011 Aug 19;12:349. doi: 10.1186/1471-2105-12-349.
Immunosignaturing is a new peptide microarray based technology for profiling of humoral immune responses. Despite new challenges, immunosignaturing gives us the opportunity to explore new and fundamentally different research questions. In addition to classifying samples based on disease status, the complex patterns and latent factors underlying immunosignatures, which we attempt to model, may have a diverse range of applications.
We investigate the utility of a number of statistical methods to determine model performance and address challenges inherent in analyzing immunosignatures. Some of these methods include exploratory and confirmatory factor analyses, classical significance testing, structural equation and mixture modeling.
We demonstrate an ability to classify samples based on disease status and show that immunosignaturing is a very promising technology for screening and presymptomatic screening of disease. In addition, we are able to model complex patterns and latent factors underlying immunosignatures. These latent factors may serve as biomarkers for disease and may play a key role in a bioinformatic method for antibody discovery.
Based on this research, we lay out an analytic framework illustrating how immunosignatures may be useful as a general method for screening and presymptomatic screening of disease as well as antibody discovery.
免疫签名是一种新的肽微阵列技术,用于分析体液免疫反应。尽管存在新的挑战,但免疫签名为我们提供了探索新的、根本不同的研究问题的机会。除了根据疾病状态对样本进行分类外,我们试图建模的免疫签名背后的复杂模式和潜在因素可能具有广泛的应用。
我们研究了许多统计方法的实用性,以确定模型性能并解决分析免疫签名所固有的挑战。其中一些方法包括探索性和验证性因素分析、经典显著性检验、结构方程和混合建模。
我们证明了基于疾病状态对样本进行分类的能力,并表明免疫签名是一种非常有前途的疾病筛查和无症状筛查技术。此外,我们能够对免疫签名背后的复杂模式和潜在因素进行建模。这些潜在因素可以作为疾病的生物标志物,并可能在抗体发现的生物信息学方法中发挥关键作用。
基于这项研究,我们提出了一个分析框架,说明了免疫签名如何作为一种用于疾病筛查和无症状筛查以及抗体发现的通用方法的用途。